H

Hyperfine Inc
NASDAQ:HYPR

Watchlist Manager
Hyperfine Inc
NASDAQ:HYPR
Watchlist
Price: 0.805 USD 0.63% Market Closed
Market Cap: 62.7m USD

Relative Value

The Relative Value of one HYPR stock under the Base Case scenario is 0.369 USD. Compared to the current market price of 0.805 USD, Hyperfine Inc is Overvalued by 54%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HYPR Relative Value
Base Case
0.369 USD
Overvaluation 54%
Relative Value
Price
H
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
21
vs Industry
27
Median 3Y
4
Median 5Y
0
Industry
2.3
Forward
4.3
vs History
vs Industry
Median 3Y
-2
Median 5Y
0
Industry
22
Forward
-1.7
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
0
Industry
14.3
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
0
Industry
20
vs History
8
vs Industry
62
Median 3Y
1
Median 5Y
0.8
Industry
2.2
vs History
5
vs Industry
64
Median 3Y
-0.5
Median 5Y
0
Industry
2.4
Forward
2
vs History
5
vs Industry
64
Median 3Y
-1.1
Median 5Y
0
Industry
5
vs History
vs Industry
57
Median 3Y
-1
Median 5Y
0
Industry
11.6
Forward
-0.8
vs History
vs Industry
54
Median 3Y
-1
Median 5Y
0
Industry
15.9
Forward
-0.8
vs History
vs Industry
58
Median 3Y
-1.1
Median 5Y
0
Industry
14.3
vs History
vs Industry
48
Median 3Y
-1.1
Median 5Y
0
Industry
18
vs History
10
vs Industry
71
Median 3Y
0.6
Median 5Y
-0.3
Industry
1.8

Multiples Across Competitors

HYPR Competitors Multiples
Hyperfine Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Hyperfine Inc
NASDAQ:HYPR
62.7m USD 5.3 -1.6 -0.7 -0.7
US
Abbott Laboratories
NYSE:ABT
227.7B USD 5.4 16.9 21.9 31.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
183.6B USD 21.1 74.1 59.7 72.6
US
Boston Scientific Corp
NYSE:BSX
153.1B USD 8.7 75.3 35.5 49.4
US
Stryker Corp
NYSE:SYK
149.2B USD 6.4 52.2 25.8 31.1
IE
Medtronic PLC
NYSE:MDT
114.4B USD 3.4 24.5 13.7 19.5
DE
Siemens Healthineers AG
XETRA:SHL
51.8B EUR 2.2 24.8 13.9 19.3
US
Becton Dickinson and Co
NYSE:BDX
51.1B USD 2.4 33.6 13.4 25
US
Edwards Lifesciences Corp
NYSE:EW
45.2B USD 8.2 10.8 24.8 27.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
42.5B USD 10.8 47.5 33.7 37.6
US
Resmed Inc
NYSE:RMD
37B USD 7.4 28.2 20.1 22.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
H
Hyperfine Inc
NASDAQ:HYPR
Average EV/EBITDA: 26.2
Negative Multiple: -0.7
N/A N/A
US
Abbott Laboratories
NYSE:ABT
21.9
13%
1.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
59.7
24%
2.5
US
Boston Scientific Corp
NYSE:BSX
35.5
21%
1.7
US
Stryker Corp
NYSE:SYK
25.8
12%
2.1
IE
Medtronic PLC
NYSE:MDT
13.7
7%
2
DE
Siemens Healthineers AG
XETRA:SHL
13.9
14%
1
US
Becton Dickinson and Co
NYSE:BDX
13.4
11%
1.2
US
Edwards Lifesciences Corp
NYSE:EW
24.8
12%
2.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
33.7
12%
2.8
US
Resmed Inc
NYSE:RMD
20.1
12%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
H
Hyperfine Inc
NASDAQ:HYPR
Average EV/EBIT: 33.6
Negative Multiple: -0.7
N/A N/A
US
Abbott Laboratories
NYSE:ABT
31.4
22%
1.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
72.6
26%
2.8
US
Boston Scientific Corp
NYSE:BSX
49.4
31%
1.6
US
Stryker Corp
NYSE:SYK
31.1
16%
1.9
IE
Medtronic PLC
NYSE:MDT
19.5
15%
1.3
DE
Siemens Healthineers AG
XETRA:SHL
19.3
19%
1
US
Becton Dickinson and Co
NYSE:BDX
25
28%
0.9
US
Edwards Lifesciences Corp
NYSE:EW
27.3
12%
2.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
37.6
12%
3.1
US
Resmed Inc
NYSE:RMD
22.8
14%
1.6